Vogt Frederick G

Chief Executive Officer

C-suiteM

US·SEC (Form 4)

Iovance Biotherapeutics, INC.

0

Total declarations

0

Company

€6,045

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Browse the detailed record of transactions filed by Vogt Frederick G, Chief Executive Officer. Director active across 1 companies, notably Iovance Biotherapeutics, INC.. In total, 1 disclosures have been published. Total volume traded: €6k. The latest transaction was disclosed on 1 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.

Declarations1 total

Executives▲PurchaseIIovance Biotherapeutics, INC.◆Signal · 56SEC

V

Vogt Frederick GInterim CEO & General Counsel

€6,0451,000 shares@ €6.0446100.0% of flow

Common Stock

SEC:0001104659-22-067758:0·1 Jun 2022

Ideal exit: 26 Feb 2023 (T+270)

SEC ↗

1 of 1 declaration

About Vogt Frederick G

Frederick G. Vogt is the Interim CEO and General Counsel of IOVANCE BIOTHERAPEUTICS, INC. In this role, he oversees legal affairs and the strategic direction of the company. His expertise is essential in ensuring compliance and growth for IOVANCE.